Literature DB >> 22930568

High order interactions of xenobiotic metabolizing genes and P53 codon 72 polymorphisms in acute leukemia.

Pradeep Singh Chauhan1, Rakhshan Ihsan, Ashwani Kumar Mishra, Dhirendra Singh Yadav, Sumita Saluja, Vishakha Mittal, Sunita Saxena, Sujala Kapur.   

Abstract

Polymorphisms in xenobiotic metabolizing genes are associated with altered metabolism of carcinogens in acute leukemia (AL). This study applied two data mining approaches to explore potential interactions among P53 and xenobiotic metabolizing genes in 230 AL patients [131 acute myeloid leukemia (AML) and 99 acute lymphoblastic leukemia (ALL)] and 199 controls. Individually, none of the genotypes showed significant associations with AML risk. However, in ALL the CYP1A12A TC genotype was associated with increased risk (OR = 2.02; 95% CI = 1.14-3.58; P = 0.01), whereas the GSTM1 null genotype imparted reduced risk (OR = 0.55; 95% CI = 0.31-0.96; P = 0.03). In classification and regression tree analysis, combinations of GSTM1 present, CYP1A12C AA or GG, EPHX1 exon3 TC, and EPHX1 exon4 AA or GG genotype strongly enhanced the risk of AML (OR = 5.89; 95% CI = 1.40-26.62; P = 0.01). In ALL, combinations of CYP1A12A TT, P53 GG or CC and GSTP1 AG genotypes conferred the highest risk (OR = 4.19; 95% CI = 1.45-12.25; P = 0.004). In multifactor dimensionality reduction analysis, a four locus model (GSTP1, P53, EPHX1 exon3, and CYP1A12A) was the best predictor model for ALL risk. The association between this model and ALL risk remained true even at low prior probabilities of 0.01% (false positive report probability = 0.05). Interaction entropy interpretations of the best model of ALL revealed that two-way interactions were mostly synergistic. These results suggest that high order gene-gene interactions play an important role in AL risk.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22930568     DOI: 10.1002/em.21723

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  11 in total

1.  Glutathione S-Transferase P1 313 (A > G) Ile105Val Polymorphism Contributes to Cancer Susceptibility in Indian Population: A Meta-analysis of 39 Case-Control Studies.

Authors:  Raju K Mandal; Rama D Mittal
Journal:  Indian J Clin Biochem       Date:  2018-09-17

2.  No evidence of correlation between p53 codon 72 G > C gene polymorphism and cancer risk in Indian population: a meta-analysis.

Authors:  Raju K Mandal; Suraj S Yadav; Aditya K Panda
Journal:  Tumour Biol       Date:  2014-05-28

3.  Polymorphisms in xenobiotic metabolizing genes (EPHX1, NQO1 and PON1) in lymphoma susceptibility: a case control study.

Authors:  Pablo Conesa-Zamora; Javier Ruiz-Cosano; Daniel Torres-Moreno; Ignacio Español; María D Gutiérrez-Meca; Javier Trujillo-Santos; Elena Pérez-Ceballos; Rocío González-Conejero; Javier Corral; Vicente Vicente; Miguel Pérez-Guillermo
Journal:  BMC Cancer       Date:  2013-05-07       Impact factor: 4.430

4.  Quantitative assessment of the influence of EPHX1 gene polymorphisms and cancer risk: a meta-analysis with 94,213 subjects.

Authors:  Xiaoqin Yang; Yubing Wang; Guiping Wang
Journal:  J Exp Clin Cancer Res       Date:  2014-09-28

5.  Analysis of possible genetic risk factors contributing to development of childhood acute lymphoblastic leukaemia in the Latvian population.

Authors:  Madara Kreile; Linda Piekuse; Dmitrijs Rots; Zane Dobele; Zhanna Kovalova; Baiba Lace
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

6.  Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.

Authors:  Xin Tian; Shundong Dai; Jing Sun; Shenyi Jiang; Youhong Jiang
Journal:  Sci Rep       Date:  2016-04-07       Impact factor: 4.379

7.  Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis.

Authors:  Xiao-Lan Ruan; Sheng Li; Peiliang Geng; Xian-Tao Zeng; Guo-Zheng Yu; Xiang-Yu Meng; Qing-Ping Gao; Xu-Bin Ao
Journal:  Med Sci Monit       Date:  2015-10-09

Review 8.  Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System.

Authors:  Haneen Banjar; David Adelson; Fred Brown; Naeem Chaudhri
Journal:  Biomed Res Int       Date:  2017-07-25       Impact factor: 3.411

9.  Differential Effect of Smoking on Gene Expression in Head and Neck Cancer Patients.

Authors:  Alexandra Iulia Irimie; Cornelia Braicu; Roxana Cojocneanu; Lorand Magdo; Anca Onaciu; Cristina Ciocan; Nikolay Mehterov; Diana Dudea; Smaranda Buduru; Ioana Berindan-Neagoe
Journal:  Int J Environ Res Public Health       Date:  2018-07-23       Impact factor: 3.390

Review 10.  The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis.

Authors:  Xiao-Lan Ruan; Sheng Li; Xiang-Yu Meng; Peiliang Geng; Qing-Ping Gao; Xu-Bin Ao
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.